Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jost

Showing results (351-360 of 7,370) with videos related to

Pageof 737
Sort By:
The American Psychologist|December 19, 2007
Coda--after "The end of the end of ideology"John T Jost
Health Affairs (Project Hope)|January 8, 2014
Implementing health reform: four years laterTimothy S Jost
Health Affairs (Project Hope)|August 8, 2012
The Affordable Care Act largely survives the Supreme Court's scrutiny--but barelyTimothy Stoltzfus Jost
Canadian Medical Association Journal|March 24, 2010
NOVA SCOTIA'S CHANGING STATISTICSA C Jost
Virchows Archiv. B, Cell Pathology Including Molecular Pathology|January 1, 1989
Cell cycle of normal bladder urothelium in developing and adult miceS P Jost
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|June 14, 2019
[Myopia: Epidemiology, anatomy and prevention of myopia and treatment options for progressive myopia in childhood]Jost B Jonas
The Lancet Regional Health. Europe|March 20, 2023
Chronic limb threatening disease, diabetic nephropathy and diabetic retinopathy in patients with type 1 diabetesJost B Jonas
Journal of Neural Transmission (Vienna, Austria : 1996)|September 11, 2024
Dopamine agonists in the treatment of Parkinson's disease: the show must go onWolfgang H Jost
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|September 10, 2005
The beta3-adrenergic agonist CL316,243 inhibits insulin signaling but not glucose uptake in primary human adipocytesM M Jost, P Jost, J Klein, et al.
Annales D'Oto-Laryngologie Et De Chirurgie Cervico Faciale : Bulletin De La Societe D'Oto-Laryngologie Des Hopitaux De Paris|January 1, 1987
[Use of polytetrafluoroethylene (Gore-Tex E-PTFE Soft Tissue Patch) for suspension of former facial paralysis and as reconstructive tissue]Y Levet, G Jost
Pageof 737

Showing results (351-360 of 7,370) with videos related to

Sort By:
Pageof 737
The American Psychologist|December 19, 2007
Coda--after "The end of the end of ideology"John T Jost
Health Affairs (Project Hope)|January 8, 2014
Implementing health reform: four years laterTimothy S Jost
Health Affairs (Project Hope)|August 8, 2012
The Affordable Care Act largely survives the Supreme Court's scrutiny--but barelyTimothy Stoltzfus Jost
Canadian Medical Association Journal|March 24, 2010
NOVA SCOTIA'S CHANGING STATISTICSA C Jost
Virchows Archiv. B, Cell Pathology Including Molecular Pathology|January 1, 1989
Cell cycle of normal bladder urothelium in developing and adult miceS P Jost
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|June 14, 2019
[Myopia: Epidemiology, anatomy and prevention of myopia and treatment options for progressive myopia in childhood]Jost B Jonas
The Lancet Regional Health. Europe|March 20, 2023
Chronic limb threatening disease, diabetic nephropathy and diabetic retinopathy in patients with type 1 diabetesJost B Jonas
Journal of Neural Transmission (Vienna, Austria : 1996)|September 11, 2024
Dopamine agonists in the treatment of Parkinson's disease: the show must go onWolfgang H Jost
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|September 10, 2005
The beta3-adrenergic agonist CL316,243 inhibits insulin signaling but not glucose uptake in primary human adipocytesM M Jost, P Jost, J Klein, et al.
Annales D'Oto-Laryngologie Et De Chirurgie Cervico Faciale : Bulletin De La Societe D'Oto-Laryngologie Des Hopitaux De Paris|January 1, 1987
[Use of polytetrafluoroethylene (Gore-Tex E-PTFE Soft Tissue Patch) for suspension of former facial paralysis and as reconstructive tissue]Y Levet, G Jost
Pageof 737